Understanding the Global Lamotrigine Trade Landscape Lamotrigine, marketed under brand names such as Lamictal, is a phenyltriazine anticonvulsant used in the long-term management of epilepsy and bipolar disorder. The global lamotrigine market has demonstrated sustained growth, valued at approximately $1.05 billion in 2025 and projected to reach $1.67 billion by 2035, representing a compound annual growth rate of 9.5%. This growth trajectory is driven by rising epilepsy prevalence, expanded clinical acceptance in bipolar disorder treatment, and the availability of extended-release formulations that improve patient adherence. For exporters, API manufacturers, and wholesale distributors, understanding who the active buyers are—and where they operate—is essential for market entry and supply chain optimization. Trade…